The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival impact of surgical management in reference centers for retroperitoneal sarcoma: A nationwide study of FSG-GETO and NETSARC.
 
Sylvie Bonvalot
No Relationships to Disclose
 
Elodie Gaignard
No Relationships to Disclose
 
Eberhard Stoeckle
No Relationships to Disclose
 
Charles Honoré
No Relationships to Disclose
 
Pierre Meeus
No Relationships to Disclose
 
Nicolas Penel
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag
 
Gwennael Ferron
No Relationships to Disclose
 
Nelly Firmin
No Relationships to Disclose
 
Florence Duffaud
No Relationships to Disclose
 
Antonio Di Marco
No Relationships to Disclose
 
Emmanuelle Bompas
No Relationships to Disclose
 
Maria Rios
No Relationships to Disclose
 
François Bertucci
No Relationships to Disclose
 
Nicolas Isambert
Travel, Accommodations, Expenses - AstraZeneca; Celgene; MedImmune; Novartis; PharmaMar; Roche/Genentech
 
Antoine Italiano
No Relationships to Disclose
 
Isabelle Laure Ray-Coquard
Honoraria - AstraZeneca; PharmaMar; Roche
Consulting or Advisory Role - Abbvie; Amgen; Pfizer
 
Axel Le Cesne
Honoraria - Amgen; Bayer; Lilly; Novartis; Pfizer; PharmaMar
 
Jean Michel Coindre
No Relationships to Disclose
 
Francoise Ducimetiere
No Relationships to Disclose
 
Jean-Yves Blay
Honoraria - Bayer; GlaxoSmithKline; Lilly; Novartis; Pharmamar; Roche
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Merck; Novartis; PharmaMar; Roche
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst); Roche (Inst)
Other Relationship - Innate Pharma